Amandeep Khatter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amandeep Khatter has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Redmond
Department of General Practice RCSI University of Medicine and Health Sciences Dublin Ireland
2 shared publications - Benjamin Jacob
Department of General Practice RCSI University of Medicine and Health Sciences Dublin Ireland
1 shared publication - Frank Moriarty
School of Pharmacy and Biomolecular Sciences RCSI University of Medicine and Health Sciences Dublin Ireland
1 shared publication - Hajira Dambha-Miller
Primary Care Research Centre, University of Southampton, Southampton, UK
1 shared publication - Mark Ashworth
School of Life Course and Population Sciences, King’s College London, London, UK
1 shared publication - Michael Naughton
The Clinical Effectiveness Group, The Wolfson Institute of Population Health, Queen Mary University of London, London, UK
1 shared publication
Latest Publications
- Open Access
- 11 October 2026
- Published by Wiley in British Journal of Clinical Pharmacology
Practice‐level variation in potentially inappropriate prescribing in middle‐aged adults: A repeated cross‐sectional study in South London general practice
Aim: To quantify between‐practice variation in potentially inappropriate prescribing (PIP) among middle‐aged adults (45–64 years) in UK general practice, and to identify patient‐ and practice‐level characteristics associated with PIP. Methods: Repeated cross‐sectional study using linked data from the Lambeth DataNet and Quality Outcomes Framework across 41 GP practices in South London (2014–2019). The study included patients aged 45–64 years prescribed ≥1 medicines in each year from 2014 to 2019 ( n = 46 633–52 582). PIP was identified using the 22 PROMPT (PRescribing Optimally in Middle‐aged People's Treatments) criteria. Multilevel negative binomial regression estimated associations with patient‐ and practice‐level characteristics, expressed as rate ratios (RR) with 95% confidence intervals. Results: PIP prevalence was 18%–20%, stable across the study period. Practice‐level prevalence ranged from 14% to 24%. The SCV was 1.72 (low) and the ICC was 0.08, with approximately 8% of variance attributable to practice‐level differences. Polypharmacy was the strongest predictor (adjusted RR 4.04, 95% CI 3.96–4.11), followed by multimorbidity (RR 2.44, 95% CI 2.40–2.50). Black/African/Caribbean/Black British ethnicity was associated with lower PIP (RR 0.77, 95% CI 0.75–0.78). Practice‐based pharmacist presence and teaching practice status were associated with modestly lower PIP, while APMS contract type was associated with higher PIP (RR 1.20, 95% CI 1.10–1.32). Conclusion: Most variation occurred at the patient level, but practice organizational characteristics were also associated with PIP and warrant further investigation in an age group for which direct medicines‐optimization evidence remains limited.
- 11 October 2026
- Published by Wiley in British Journal of Clinical Pharmacology
Open AccessPractice‐level variation in potentially inappropriate prescribing in middle‐aged adults: A repeated cross‐sectional study in South London general practice
Aim: To quantify between‐practice variation in potentially inappropriate prescribing (PIP) among middle‐aged adults (45–64 years) in UK general practice, and to identify patient‐ and practice‐level characteristics associated with PIP. Methods: Repeated cross‐sectional study using linked data from the Lambeth DataNet and Quality Outcomes Framework across 41 GP practices in South London (2014–2019). The study included patients aged 45–64 years prescribed ≥1 medicines in each year from 2014 to 2019 ( n = 46 633–52 582). PIP was identified using the 22 PROMPT (PRescribing Optimally in Middle‐aged People's Treatments) criteria. Multilevel negative binomial regression estimated associations with patient‐ and practice‐level characteristics, expressed as rate ratios (RR) with 95% confidence intervals. Results: PIP prevalence was 18%–20%, stable across the study period. Practice‐level prevalence ranged from 14% to 24%. The SCV was 1.72 (low) and the ICC was 0.08, with approximately 8% of variance attributable to practice‐level differences. Polypharmacy was the strongest predictor (adjusted RR 4.04, 95% CI 3.96–4.11), followed by multimorbidity (RR 2.44, 95% CI 2.40–2.50). Black/African/Caribbean/Black British ethnicity was associated with lower PIP (RR 0.77, 95% CI 0.75–0.78). Practice‐based pharmacist presence and teaching practice status were associated with modestly lower PIP, while APMS contract type was associated with higher PIP (RR 1.20, 95% CI 1.10–1.32). Conclusion: Most variation occurred at the patient level, but practice organizational characteristics were also associated with PIP and warrant further investigation in an age group for which direct medicines‐optimization evidence remains limited.
- Open Access
- 1 June 2021
- Published by Wiley in Learned Publishing
- Vol. 34 (4) , 568-577
Is rapid scientific publication also high quality? Bibliometric analysis of highly disseminated COVID‐19 research papers
The impact of COVID‐19 has underlined the need for reliable information to guide clinical practice and policy. This urgency has to be balanced against disruption to journal handling capacity and the continued need to ensure scientific rigour. We examined the reporting quality of highly disseminated COVID‐19 research papers using a bibliometric analysis examining reporting quality and risk of bias (RoB) amongst 250 top scoring Altmetric Attention Score (AAS) COVID‐19 research papers between January and April 2020. Method‐specific RoB tools were used to assess quality. After exclusions, 84 studies from 44 journals were included. Forty‐three (51%) were case series/studies, and only one was an randomized controlled trial. Most authors were from institutions based in China (n = 44, 52%). The median AAS and impact factor was 2015 (interquartile range [IQR] 1,105–4,051.5) and 12.8 (IQR 5–44.2) respectively. Nine studies (11%) utilized a formal reporting framework, 62 (74%) included a funding statement, and 41 (49%) were at high RoB. This review of the most widely disseminated COVID‐19 studies highlights a preponderance of low‐quality case series with few research papers adhering to good standards of reporting. It emphasizes the need for cautious interpretation of research and the increasingly vital responsibility that journals have in ensuring high‐quality publications.
- 1 June 2021
- Published by Wiley in Learned Publishing
- Vol. 34 (4) , 568-577
Open AccessIs rapid scientific publication also high quality? Bibliometric analysis of highly disseminated COVID‐19 research papers
The impact of COVID‐19 has underlined the need for reliable information to guide clinical practice and policy. This urgency has to be balanced against disruption to journal handling capacity and the continued need to ensure scientific rigour. We examined the reporting quality of highly disseminated COVID‐19 research papers using a bibliometric analysis examining reporting quality and risk of bias (RoB) amongst 250 top scoring Altmetric Attention Score (AAS) COVID‐19 research papers between January and April 2020. Method‐specific RoB tools were used to assess quality. After exclusions, 84 studies from 44 journals were included. Forty‐three (51%) were case series/studies, and only one was an randomized controlled trial. Most authors were from institutions based in China (n = 44, 52%). The median AAS and impact factor was 2015 (interquartile range [IQR] 1,105–4,051.5) and 12.8 (IQR 5–44.2) respectively. Nine studies (11%) utilized a formal reporting framework, 62 (74%) included a funding statement, and 41 (49%) were at high RoB. This review of the most widely disseminated COVID‐19 studies highlights a preponderance of low‐quality case series with few research papers adhering to good standards of reporting. It emphasizes the need for cautious interpretation of research and the increasingly vital responsibility that journals have in ensuring high‐quality publications.